Cargando…
A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
Pantothenate kinase-associated neurodegeneration (PKAN) is the most common form of neurodegeneration with brain iron accumulation, it is an autosomal recessive disease due to mutation in PANK 2 on chromosome 20, which causes the accumulation of iron in basal ganglia and production of free radicals t...
Autores principales: | Rohani, Mohammad, Razmeh, Saeed, Shahidi, Gholam Ali, Alizadeh, Elham, Orooji, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865300/ https://www.ncbi.nlm.nih.gov/pubmed/29619158 http://dx.doi.org/10.4081/ni.2017.7279 |
Ejemplares similares
-
Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments
por: Razmeh, Saeed, et al.
Publicado: (2018) -
A novel homozygous variation in the PANK2 gene in two Persian siblings with atypical pantothenate kinase associated neurodegeneration
por: Habibi, Amir Hasan, et al.
Publicado: (2019) -
Treatment of Pantothenate-Kinase Neurodegeneration With Baclofen, Botulinum Toxin, and Deferiprone: A Case Report
por: Hameed, Marya, et al.
Publicado: (2023) -
Treatment of Levodopainduced dyskinesia with Vitamin D: A Randomized, double-blind, placebo-controlled trial
por: Habibi, Amir Hassan, et al.
Publicado: (2018) -
Pantothenate kinase-associated neurodegeneration
por: Hundallah, Khalid, et al.
Publicado: (2017)